Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.The Southern CSI A500ETF Link Fund was added with Y share, which was included in the list of individual pensions. Four products from southern fund were shortlisted for individual pensions, including the Southern CSI A500ETF Link Fund, and Y share was added with code 022918. Its target ETF-CSI A500ETF South (159352) has received a net inflow of funds for 38 consecutive days, with the latest scale approaching 19 billion yuan. According to the data of China Merchants Securities Fund Evaluation Center, in the past 10 years, South Stock ETF has been the most accurate in tracking, ranking first in its kind. Investors can borrow the layout of the A500ETF South (159352) and its linked funds (A 022434, C 022435, Y 022918).The tenth batch of national procurement officially opened, and the number of enterprises and varieties involved reached a record high. The tenth batch of centralized drug procurement organized by the state officially accepted the application materials of enterprises at 8: 00 this morning at No.398 Zhanyuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involved 62 varieties and 263 product specifications, and the number of enterprises and varieties involved reached a record high. Among them, 33 enterprises competed for nine short-listed oral sustained-release formulations of sitagliptin. There are also a number of varieties that are billions in the market of public hospitals, such as doxorubicin hydrochloride liposome injection, cefoperazone injection, piperacillin injection, compound α -ketoacid oral sustained-release dosage form, norepinephrine injection and aspirin oral sustained-release dosage form. The sales scale in sample hospitals last year all exceeded 2 billion yuan. Hengrui Pharma, Kelun Pharmaceutical, Unacon and Zhengda Tianqing participated with many varieties. Note: According to the tenth batch of national adoption documents released before, the tenth batch of national adoption rules have changed a lot, such as canceling the protection mechanism of 50% price reduction and increasing the fuse recovery mechanism by 1.8 times, and the number of B-certified enterprises affects the number of final finalists.
Zhonggong Education: Director Yi Ziting resigned due to retirement. Zhonggong Education announced that the company's board of directors recently received a written resignation report from Director Yi Ziting. Yi Ziting applied to the company's board of directors for resignation due to retirement, and will not hold other positions in the company after resignation.CEO of STELLANTIS Europe: We will never pay a fine for the EU emission reduction requirements in 2025, and we are ready to reduce production to avoid this situation.Hongjiu Fruit: Jiang Zongying, the controlling shareholder and executive director, pledged 21 million H shares of the company. Hongjiu Fruit (06689) announced that the company had learned that Ms. Jiang Zongying, the controlling shareholder and executive director of the company, had pledged the company's shares on December 11, 2024. Because the company failed to return the relevant funds to the subscriber within the time limit stipulated in the termination agreement, Ms. Jiang pledged 21 million H shares of the company to the subscriber as the company's subsequent refund of the relevant funds to the subscriber.
Truck manufacturer Paccar recalled more than 220,000 American cars due to electronic system problems. The National Highway Traffic Safety Administration (NHTSA) said on Thursday that truck manufacturer Paccar recalled 220,972 cars in the United States because there was a problem with the electronic control unit (ECU), which might affect the systems related to braking and stability control. NHTSA said that the recalled vehicles included some Peterbilt and Kenworth cars produced in 2021-2025.Yin Zhongyu, Federal Reserve Securities: Industrial M&A will always have the opportunity to cross-border M&A and will never be supported on a large scale. Yin Zhongyu, assistant to the president of Federal Reserve Securities and head of the M&A business department, pointed out that M&A has ushered in a rare policy window. For industrial M&A, the policy window has always been there. "In particular, industrial M&A focusing on new productivity has always been the direction encouraged by the regulatory authorities, and there will always be opportunities. However, for buying and selling shells and cross-border restructuring, related risks need to be vigilant, and cross- (21 Finance)Institution: The Swiss National Bank does not need to cut interest rates sharply again. Melanie Debono, a macroeconomic analyst at Pantheon, wrote in a report that the Swiss National Bank does not need to cut borrowing costs sharply again. Earlier, the Swiss National Bank unexpectedly cut interest rates by 50 basis points. Most analysts had expected a more cautious rate cut of 25 basis points. Debono said that there may be further relaxation after this move, but only a little. Pantheon Macroeconomics predicts that the Swiss National Bank will cut interest rates by 25 basis points again in March next year.
Strategy guide
Strategy guide
12-14
Strategy guide 12-14